ABUS logo

Arbutus Biopharma (ABUS) Net income

annual net income:

-$69.92M+$2.93M(+4.02%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ABUS annual net profit is -$69.92 million, with the most recent change of +$2.93 million (+4.02%) on December 31, 2024.
  • During the last 3 years, ABUS annual net income has risen by +$6.33 million (+8.30%).
  • ABUS annual net income is now -336.13% below its all-time high of $29.61 million, reached on December 31, 2012.

Performance

ABUS Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

quarterly net income:

-$24.53M-$11.99M(-95.71%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ABUS quarterly net profit is -$24.53 million, with the most recent change of -$11.99 million (-95.71%) on March 31, 2025.
  • Over the past year, ABUS quarterly net income has dropped by -$6.65 million (-37.21%).
  • ABUS quarterly net income is now -164.09% below its all-time high of $38.27 million, reached on December 31, 2012.

Performance

ABUS quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

TTM net income:

-$76.57M-$6.65M(-9.51%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ABUS TTM net profit is -$76.57 million, with the most recent change of -$6.65 million (-9.51%) on March 31, 2025.
  • Over the past year, ABUS TTM net income has dropped by -$2.19 million (-2.94%).
  • ABUS TTM net income is now -352.39% below its all-time high of $30.34 million, reached on March 31, 2013.

Performance

ABUS TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ABUS Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.0%-37.2%-2.9%
3 y3 years+8.3%-55.6%-1.2%
5 y5 years+54.5%-76.9%+47.0%

ABUS Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.7%+8.3%-95.7%at low-11.2%+0.7%
5 y5-year-9.7%+54.5%-95.7%at low-20.1%+47.0%
alltimeall time-336.1%+81.8%-164.1%+88.8%-352.4%+80.2%

ABUS Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$24.53M(+95.7%)
-$76.57M(+9.5%)
Dec 2024
-$69.92M(-4.0%)
-$12.53M(-36.4%)
-$69.92M(-8.8%)
Sep 2024
-
-$19.72M(-0.4%)
-$76.70M(-0.5%)
Jun 2024
-
-$19.80M(+10.7%)
-$77.09M(+3.6%)
Mar 2024
-
-$17.88M(-7.4%)
-$74.39M(+2.1%)
Dec 2023
-$72.85M(+4.9%)
-$19.31M(-3.9%)
-$72.85M(-3.5%)
Sep 2023
-
-$20.10M(+17.6%)
-$75.47M(+3.5%)
Jun 2023
-
-$17.09M(+4.6%)
-$72.93M(+4.1%)
Mar 2023
-
-$16.34M(-25.5%)
-$70.03M(+0.8%)
Dec 2022
-$69.46M(-8.9%)
-$21.93M(+24.8%)
-$69.46M(+0.9%)
Sep 2022
-
-$17.57M(+23.8%)
-$68.84M(-2.3%)
Jun 2022
-
-$14.19M(-10.0%)
-$70.44M(-6.9%)
Mar 2022
-
-$15.77M(-26.1%)
-$75.63M(-0.8%)
Dec 2021
-$76.25M(+19.6%)
-$21.32M(+11.3%)
-$76.25M(+5.9%)
Sep 2021
-
-$19.16M(-1.2%)
-$71.97M(+0.6%)
Jun 2021
-
-$19.39M(+18.4%)
-$71.56M(+8.0%)
Mar 2021
-
-$16.38M(-3.9%)
-$66.27M(+4.0%)
Dec 2020
-$63.74M(-58.5%)
-$17.04M(-9.1%)
-$63.74M(-10.7%)
Sep 2020
-
-$18.75M(+33.1%)
-$71.36M(-47.2%)
Jun 2020
-
-$14.09M(+1.6%)
-$135.10M(-6.4%)
Mar 2020
-
-$13.86M(-43.8%)
-$144.33M(-6.1%)
Dec 2019
-$153.72M(+169.4%)
-$24.65M(-70.1%)
-$153.72M(+4.3%)
Sep 2019
-
-$82.50M(+253.9%)
-$147.32M(+65.0%)
Jun 2019
-
-$23.32M(+0.3%)
-$89.29M(+42.0%)
Mar 2019
-
-$23.25M(+27.4%)
-$62.88M(+10.2%)
Dec 2018
-$57.06M(-32.4%)
-$18.25M(-25.4%)
-$57.06M(-23.7%)
Sep 2018
-
-$24.47M(-891.8%)
-$74.74M(+20.8%)
Jun 2018
-
$3.09M(-117.7%)
-$61.87M(-25.7%)
Mar 2018
-
-$17.43M(-51.5%)
-$83.22M(-1.4%)
Dec 2017
-$84.41M(-78.0%)
-$35.93M(+209.8%)
-$84.41M(-68.4%)
Sep 2017
-
-$11.60M(-36.5%)
-$267.18M(-2.9%)
Jun 2017
-
-$18.25M(-2.0%)
-$275.17M(-28.9%)
Mar 2017
-
-$18.63M(-91.5%)
-$386.92M(+0.7%)
Dec 2016
-$384.16M(+512.5%)
-$218.69M(+1016.1%)
-$384.16M(+122.9%)
Sep 2016
-
-$19.59M(-84.9%)
-$172.33M(-5.2%)
Jun 2016
-
-$130.00M(+718.9%)
-$181.72M(+172.8%)
Mar 2016
-
-$15.87M(+131.4%)
-$66.60M(+6.2%)
Dec 2015
-$62.72M
-$6.86M(-76.3%)
-$62.72M(+1.1%)
Sep 2015
-
-$28.98M(+94.7%)
-$62.02M(+48.9%)
Jun 2015
-
-$14.89M(+24.2%)
-$41.65M(+26.8%)
DateAnnualQuarterlyTTM
Mar 2015
-
-$11.99M(+94.4%)
-$32.84M(-15.4%)
Dec 2014
-$38.84M(+176.2%)
-$6.17M(-28.3%)
-$38.84M(+10.1%)
Sep 2014
-
-$8.60M(+41.5%)
-$35.27M(+8.3%)
Jun 2014
-
-$6.08M(-66.2%)
-$32.57M(+10.4%)
Mar 2014
-
-$17.98M(+592.2%)
-$29.50M(+109.8%)
Dec 2013
-$14.06M(-147.5%)
-$2.60M(-56.0%)
-$14.06M(-152.5%)
Sep 2013
-
-$5.91M(+95.9%)
$26.80M(-8.3%)
Jun 2013
-
-$3.01M(+18.4%)
$29.22M(-3.7%)
Mar 2013
-
-$2.55M(-106.7%)
$30.34M(+2.1%)
Dec 2012
$29.61M(-393.7%)
$38.27M(-1196.3%)
$29.72M(-374.5%)
Sep 2012
-
-$3.49M(+84.6%)
-$10.83M(+23.7%)
Jun 2012
-
-$1.89M(-40.3%)
-$8.75M(-16.7%)
Mar 2012
-
-$3.17M(+39.0%)
-$10.51M(-0.2%)
Dec 2011
-$10.08M(-18.8%)
-$2.28M(+60.9%)
-$10.53M(+0.9%)
Sep 2011
-
-$1.42M(-61.2%)
-$10.44M(-8.2%)
Jun 2011
-
-$3.65M(+14.4%)
-$11.38M(-0.9%)
Mar 2011
-
-$3.19M(+45.6%)
-$11.48M(-7.2%)
Dec 2010
-$12.41M(+48.6%)
-$2.19M(-7.1%)
-$12.38M(+4.5%)
Sep 2010
-
-$2.35M(-37.3%)
-$11.85M(-2.4%)
Jun 2010
-
-$3.75M(-8.1%)
-$12.15M(+17.6%)
Mar 2010
-
-$4.08M(+146.1%)
-$10.33M(+30.9%)
Dec 2009
-$8.36M(-28.7%)
-$1.66M(-37.3%)
-$7.89M(+8.4%)
Sep 2009
-
-$2.65M(+36.6%)
-$7.28M(-29.5%)
Jun 2009
-
-$1.94M(+17.9%)
-$10.32M(-21.5%)
Mar 2009
-
-$1.64M(+57.2%)
-$13.14M(+10.3%)
Dec 2008
-$11.72M(+353.7%)
-$1.05M(-81.6%)
-$11.91M(+13.4%)
Sep 2008
-
-$5.69M(+19.6%)
-$10.51M(+218.0%)
Jun 2008
-
-$4.76M(+1028.7%)
-$3.31M(-2.0%)
Mar 2008
-
-$421.50K(-217.8%)
-$3.37M(+14.3%)
Dec 2007
-$2.58M(-114.3%)
$357.90K(-76.4%)
-$2.95M(-10.8%)
Sep 2007
-
$1.52M(-131.4%)
-$3.31M(-31.4%)
Jun 2007
-
-$4.82M
-$4.82M
Dec 2006
$18.08M(-324.3%)
-
-
Dec 2005
-$8.06M(-71.3%)
-
-
Dec 2004
-$28.05M(-8.4%)
-
-
Dec 2003
-$30.61M(-0.8%)
-
-
Dec 2002
-$30.87M(+120.3%)
-
-
Dec 2001
-$14.02M(+52.3%)
-
-
Dec 2000
-$9.20M(+12.6%)
-
-
Dec 1999
-$8.17M(-6.6%)
-
-
Dec 1998
-$8.75M
-
-

FAQ

  • What is Arbutus Biopharma annual net profit?
  • What is the all time high annual net income for Arbutus Biopharma?
  • What is Arbutus Biopharma annual net income year-on-year change?
  • What is Arbutus Biopharma quarterly net profit?
  • What is the all time high quarterly net income for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly net income year-on-year change?
  • What is Arbutus Biopharma TTM net profit?
  • What is the all time high TTM net income for Arbutus Biopharma?
  • What is Arbutus Biopharma TTM net income year-on-year change?

What is Arbutus Biopharma annual net profit?

The current annual net income of ABUS is -$69.92M

What is the all time high annual net income for Arbutus Biopharma?

Arbutus Biopharma all-time high annual net profit is $29.61M

What is Arbutus Biopharma annual net income year-on-year change?

Over the past year, ABUS annual net profit has changed by +$2.93M (+4.02%)

What is Arbutus Biopharma quarterly net profit?

The current quarterly net income of ABUS is -$24.53M

What is the all time high quarterly net income for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly net profit is $38.27M

What is Arbutus Biopharma quarterly net income year-on-year change?

Over the past year, ABUS quarterly net profit has changed by -$6.65M (-37.21%)

What is Arbutus Biopharma TTM net profit?

The current TTM net income of ABUS is -$76.57M

What is the all time high TTM net income for Arbutus Biopharma?

Arbutus Biopharma all-time high TTM net profit is $30.34M

What is Arbutus Biopharma TTM net income year-on-year change?

Over the past year, ABUS TTM net profit has changed by -$2.19M (-2.94%)
On this page